ID: ALA2370904

Max Phase: Preclinical

Molecular Formula: C50H72N14O11

Molecular Weight: 1045.21

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)C(N)CC(N)=O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C50H72N14O11/c1-5-28(4)41(47(72)60-36(23-31-25-55-26-57-31)48(73)64-20-10-14-38(64)45(70)61-37(49(74)75)22-29-11-7-6-8-12-29)63-44(69)35(21-30-15-17-32(65)18-16-30)59-46(71)40(27(2)3)62-43(68)34(13-9-19-56-50(53)54)58-42(67)33(51)24-39(52)66/h6-8,11-12,15-18,25-28,33-38,40-41,65H,5,9-10,13-14,19-24,51H2,1-4H3,(H2,52,66)(H,55,57)(H,58,67)(H,59,71)(H,60,72)(H,61,70)(H,62,68)(H,63,69)(H,74,75)(H4,53,54,56)/t28-,33?,34-,35-,36-,37-,38-,40-,41-/m0/s1

Standard InChI Key:  MPKNWWOXPCCKSV-JXRHJSDVSA-N

Associated Targets(non-human)

Angiotensin II type 2 (AT-2) receptor 803 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1045.21Molecular Weight (Monoisotopic): 1044.5505AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Samanen J, Narindray D, Cash T, Brandeis E, Adams W, Yellin T, Eggleston D, DeBrosse C, Regoli D..  (1989)  Potent angiotensin II antagonists with non-beta-branched amino acids in position 5.,  32  (2): [PMID:2913307] [10.1021/jm00122a030]

Source